Patent · US Active

Synthetic mammalian signaling circuits for robust cell population control

US11999964B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2021
Grant dateJun 4, 2024
Priority date
Expiry dateNov 24, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/10
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein include circuits, compositions, nucleic acids, populations, systems, and methods enabling cells to sense, control, and/or respond to their own population size. In some embodiments, an orthogonal communication channel allows specific communication between engineered cells. Also described herein, in some embodiments, is an evolutionarily robust ‘paradoxical’ regulatory circuit architecture in which orthogonal signals both stimulate and inhibit net cell growth at different signal concentrations. In some embodiments, engineered cells autonomously reach designed densities and/or activate therapeutic or safety programs at specific density thresholds. Methods of treatment are also provided in some embodiments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.